Gene Review:
NRSN1 - neurensin 1
Homo sapiens
Synonyms:
Neurensin-1, Neuro-p24, VMP, Vesicular membrane protein of 24 kDa, Vesicular membrane protein p24, ...
- Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: results of a multicenter phase 1/2 study. Mateos, M.V., Hernández, J.M., Hernández, M.T., Gutiérrez, N.C., Palomera, L., Fuertes, M., Díaz-Mediavilla, J., Lahuerta, J.J., de la Rubia, J., Terol, M.J., Sureda, A., Bargay, J., Ribas, P., de Arriba, F., Alegre, A., Oriol, A., Carrera, D., García-Laraña, J., García-Sanz, R., Bladé, J., Prósper, F., Mateo, G., Esseltine, D.L., van de Velde, H., Miguel, J.F. Blood (2006)
- Mitoxantrone versus doxorubicin in combination chemotherapy for advanced carcinoma of the breast. Leonard, R.C., Cornbleet, M.A., Kaye, S.B., Soukop, M., White, G., Hutcheon, A.W., Robinson, S., Kerr, M.E., Smyth, J.F. J. Clin. Oncol. (1987)
- A prospective study of a new combination chemotherapy regimen in patients older than 70 years with unfavorable non-Hodgkin's lymphoma. Tirelli, U., Zagonel, V., Errante, D., Serraino, D., Talamini, R., De Cicco, M., Carbone, A., Monfardini, S. J. Clin. Oncol. (1992)
- Genetic and immunological analyses of Vls (VMP-like sequences) of Borrelia burgdorferi. Kawabata, H., Myouga, F., Inagaki, Y., Murai, N., Watanabe, H. Microb. Pathog. (1998)
- Treatment of lymphoma in the elderly: an update. Tirelli, U., Zagonel, V., Errante, D., Fratino, L., Monfardini, S. Rays. (1997)
- Strong genetic evidence of DCDC2 as a susceptibility gene for dyslexia. Schumacher, J., Anthoni, H., Dahdouh, F., König, I.R., Hillmer, A.M., Kluck, N., Manthey, M., Plume, E., Warnke, A., Remschmidt, H., Hülsmann, J., Cichon, S., Lindgren, C.M., Propping, P., Zucchelli, M., Ziegler, A., Peyrard-Janvid, M., Schulte-Körne, G., Nöthen, M.M., Kere, J. Am. J. Hum. Genet. (2006)
- Event-related potentials during digit recognition tasks. Ji, J., Porjesz, B., Chorlian, D., Begleiter, H. Brain research. Cognitive brain research. (1998)
- Cloning, expression and characterization of a novel human VMP gene. Cheng, C., Xu, J., Ye, X., Dai, J., Wu, Q., Zeng, L., Wang, L., Zhao, W., Ji, C., Gu, S., Xie, Y., Mao, Y. Mol. Biol. Rep. (2002)
- Second-line chemotherapy in human immunodeficiency virus-related non-Hodgkin's lymphoma: evidence of activity of a combination of etoposide, mitoxantrone, and prednimustine in relapsed patients. Tirelli, U., Errante, D., Spina, M., Gastaldi, R., Nigra, E., Nosari, A.M., Magnani, G., Vaccher, E. Cancer (1996)
- Phase III study of intermittent 5-drug regimen (VBCMP) versus intermittent 3-drug regimen (VMP) versus intermittent melphalan and prednisone (MP) in myelomatosis. Hansen, O.P., Clausen, N.A., Drivsholm, A., Laursen, B. Scandinavian journal of haematology. (1985)
- CHOP is the standard regimen in patients > or = 70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group. Tirelli, U., Errante, D., Van Glabbeke, M., Teodorovic, I., Kluin-Nelemans, J.C., Thomas, J., Bron, D., Rosti, G., Somers, R., Zagonel, V., Noordijk, E.M. J. Clin. Oncol. (1998)
- Squamous cell carcinoma of the esophagus. Treatment by combined vincristine-methotrexate plus folinic acid rescue and cisplatin before radiotherapy. Resbeut, M., Le Prise-Fleury, E., Ben-Hassel, M., Goudier, M.J., Morice-Rouxel, M.F., Douillard, J.Y., Chenal, C. Cancer (1985)
- Results of therapy and changing prognosis of multiple myeloma during the last 40 years in the region of North and Middle Moravia: group of 562 patients. Scudla, V., Bacovsky, J., Indrak, K., Kodouskova, V., Vytrasova, M., Faber, E., Papajik, T., Adam, Z., Hajek, R., Horak, P., Martinek, A. Hematol. J. (2003)